Gene-Based Treatment for Vitiligo: Pioneering Advances in Restoring Skin Pigmentation.
Prof. Aécio D’Silva, Ph.D
AquaUniversity
Embracing a brighter future for vitiligo patients through cutting-edge gene-based treatments
Vitiligo is a chronic autoimmune disorder that causes patches of skin to lose pigment or color. Between 35 and 70 million people suffer from vitiligo globally. The cause of vitiligo is unknown, but it may be related to immune system changes, genetic factors, stress, or sun exposure. While the condition is not life-threatening, its impact on a person’s self-esteem and quality of life can be profound. Over the years, medical advancements have explored various treatment modalities, but gene-based therapies are emerging as a promising frontier. In this blog, we delve into the revolutionary potential of gene-based treatments for vitiligo and their potential to restore pigmentation, offering new hope to those affected by this condition.
Read more
